Top Banner
Designer Drug Tests Solutions for Employers
39

Designer Drugs Testing Solutions for Employers

Jun 01, 2015

Download

Health & Medicine

NMS Labs

Designer Drugs Testing Solutions for Employers
Presented February 1, 2012
by Dr. Barry K. Logan, PhD, DABFT
NMS Labs National Director of Forensic Services
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Designer Drugs Testing Solutions for Employers

Designer Drug Tests Solutionsfor Employers

Page 2: Designer Drugs Testing Solutions for Employers

SYNTHETIC MARIJUANA UPDATE

Page 3: Designer Drugs Testing Solutions for Employers

K2/Spice

Page 4: Designer Drugs Testing Solutions for Employers

K2/Spice

Page 5: Designer Drugs Testing Solutions for Employers

Marijuana

Most popular recreational drug after alcohol and tobacco.

Main psychoactive component THC

#1 Drug in the DRE program

Some 25 million Americans have smoked marijuana in the past year, and more than 14 million do so regularly.

Possession and use illegal under federal law, but states have variable policies on enforcement and prosecution.

6.8% of Friday and Saturday evening drivers test positive for use.

Page 7: Designer Drugs Testing Solutions for Employers

K2/Spice

• Chemicals used change frequently.

• Different products with same name contain different chemicals.

• The same product from the same manufacturer contains different drug, lot to lot.

Page 8: Designer Drugs Testing Solutions for Employers

K2/Spice

Page 9: Designer Drugs Testing Solutions for Employers

Synthetic Cannabinoids 2010• JWH-018• JWH-073• CP 47, 497 (C7)• CP 47,497 (C8)• HU-210

Page 10: Designer Drugs Testing Solutions for Employers

Synthetic Cannabinoid 2012

JWH-007JWH-015JWH-018JWH-018 methyl hexyl homologJWH-019JWH-073JWH-073 methyl butyl homologJWH-081JWH-122JWH-133JWH-175JWH-200JWH-201JWH-203JWH-210JWH-250JWH-251JWH-302JWH-398

CP 47, 497 (C7)CP 47,497 (C8) CP 55,940AM-694AM-1220AM-1241AM-2201AM-2233RCS-4RCS-8WIN 48,098 (Pravadoline)WIN 55,212-2WIN 55,212-3CB-25CB-52

HU-210HU-211HU-308HU-331JT-7770

Page 11: Designer Drugs Testing Solutions for Employers

Legal Status - FederalTemporary Scheduling3/1/2011 – Synthetic Cannabinoids–JWH-018–JWH-073–JWH-200–CP47,497 (C7)–CP47,497 (C8)

Page 12: Designer Drugs Testing Solutions for Employers

Marijuana/K2 EffectsRed eyes / bloodshotBurning of the eyes Xerostomia (dry mouth) TachycardiaChanges in perception/mood Balance and CoordinationHallucinations Sedation Subjective thought disruption/loss of concentrationImpaired sense of timeSelf assessed impairment ArrhythmiasSeizures/ConvulsionsPanic AttacksParanoia and AnxietySickness

Page 13: Designer Drugs Testing Solutions for Employers

K2/Spice Prevalence

NFLIS, Oct 2011

Calls to Poison Control Centers

Page 14: Designer Drugs Testing Solutions for Employers

K2/Spice Behavioral Effects

Page 15: Designer Drugs Testing Solutions for Employers

K2/Spice and Lethality

Page 16: Designer Drugs Testing Solutions for Employers

Synthetic Cannabinoid Metabolites Screen - Expanded, Urine (Forensic) Test (9562U)

• JWH-018 N-(4-hydroxypentyl) metabolite• JWH-018 N-(5-hydroxypentyl) metabolite• JWH-019 N-(5-hydroxyhexyl) metabolite• JWH-073 N-(3-hydroxybutyl) metabolite• JWH-073 N-(4-hydroxybutyl) metabolite• JWH-250 N-(4-hydroxypentyl) metabolite• AM-2201 N-(4-hydroxypentyl) metabolite

OO

N

OH

Urine K2/Spice – Expanded Scope

Page 17: Designer Drugs Testing Solutions for Employers

Urine K2/Spice - Positivity

Page 18: Designer Drugs Testing Solutions for Employers

Blood K2/Spice - Positivity

Page 19: Designer Drugs Testing Solutions for Employers

“BATH SALTS” UPDATE

Page 20: Designer Drugs Testing Solutions for Employers

Designer Drugs1980’s

-methylfentanyl, MPPP, MDMA,

1990’s, early 2000’s

PMA, rise of methamphetamine

Growth of the Internet

Beginnings of the “Research Chemicals” or “New Psychedelic” Movement.

Mid 2000’s

AMT, DMT, 5-MeO-DiPT

Khat, cathinone, methcathinone

Page 21: Designer Drugs Testing Solutions for Employers

Designer Stimulants and Hallucinogens

2008-2012

Benzylpiperazines (6+)BZP, TFMPP, m-CPP

“Bath Salts”-Keto amphetamines (30+)

Ephedrone, mephedrone, methylone, methedrone…

Phenethylamines (2C suite) (15+)

2C-B, 2C-E, 2C-I, 2C-B, 2C-T-7,…

Pyrrolidophenones (pyrovalerones) (20+)

-PVP, MDPV, PPP,…

Page 22: Designer Drugs Testing Solutions for Employers

Designer Stimulants and Hallucinogens

Bath Salts Products

Page 23: Designer Drugs Testing Solutions for Employers

Bath Salts Effects

ExcitementEuphoriaTachycardiaIncreased pupil sizeRapid SpeechMotor RestlessnessAnxietyParanoia

Mood Changes

Withdrawal/DepressionDelusionsHallucinationsSeizures/ConvulsionsDeath

MethEcstasy Bath Salts

Page 24: Designer Drugs Testing Solutions for Employers

Bath Salts - Prevalence

NFLIS, Oct 2011

Calls to Poison Control Centers

Page 25: Designer Drugs Testing Solutions for Employers

Legal Status - FederalTemporary Scheduling10/21/2011 “Bath Salts”

–MDPV

–Mephedrone

–Methylone

Page 26: Designer Drugs Testing Solutions for Employers

Bath Salts and Depression

Page 27: Designer Drugs Testing Solutions for Employers

Bath Salts and Violence

Page 28: Designer Drugs Testing Solutions for Employers

Bath Salts Lethality

Page 29: Designer Drugs Testing Solutions for Employers

Designer Drugs - Salvia

Page 30: Designer Drugs Testing Solutions for Employers

ANABOLIC STEROIDS UPDATE

Page 31: Designer Drugs Testing Solutions for Employers

Designer Drugs

Page 32: Designer Drugs Testing Solutions for Employers

Designer Drugs

Page 33: Designer Drugs Testing Solutions for Employers

Anabolic Steroids

Mimic Effects of Testosterone and DihydrotestosteroneIncrease protein synthesisBuildup of muscleStimulate bone growthStimulate AppetiteTreat Chronic Wasting Cause acneElevate cholesterolHypertension

Heart and Liver damageGynecomastiaTesticular atrophyMood changes/DepressionAngerViolence

Page 34: Designer Drugs Testing Solutions for Employers

9305U Anabolic Steroid Assay

• Bolasterone • Boldenone • Clenbuterol • Clostebol Metabolite • Clostebol • Creatinine • Drostanolone Metabolite • Epitestosterone • Fluoxymesterone • Methandienone Metabolite • Methandienone • Methenolone • Methyltestosterone • Nandrolone Metabolite • Nandrolone

• Nandrolone

• Norandrostenedione

• Norethandrolone Metabolite

• Norethandrolone

• Norethindrone

• Oxandrolone

• Oxymetholone Metabolite

• Probenecid

• Stanozolol Metabolite

• Stanozolol

• Testosterone/Epitestosterone Ratio

• Testosterone

• Tetrahydrogestrinone

• Trenbolone Metabolite

• Turinabol

Page 35: Designer Drugs Testing Solutions for Employers

Urine Detection Times for Steroids

Compound DetectionClenbuterol ~4 daysTestosterone Undecanoate ~1 WeekTestosterone Propionate ~ 2weeksOxandrolone ~ 3 WeeksOral Stanozolol ~ 3 Weeksmethandienone ~ 3 WeeksNoretadrolone ~ 3 WeeksOxymetholone ~2 monthsInjectable Stanozolol ~2 monthsBoldenone ~ 5 monthsTrenbolone ~ 5 monthsNandrolone ~12-18 months

Various internet sources including user input*

Page 36: Designer Drugs Testing Solutions for Employers

Most Frequently Encountered - 9305U

CompoundAbnormal Testosterone/Epi RatioNandrolone MetaboliteNandroloneNorandrostenedioneBoldenoneMethenoloneTrenbolone MetaboliteMethandienone MetaboliteStanozololMethyltestosteroneStanozolol MetaboliteMethandienone

Page 37: Designer Drugs Testing Solutions for Employers

Testosterone:Epitestosterone

RatioNormal Range, less than 4.0~3% have concentrations greater than 4.0Range: 4.1 – 420

Page 38: Designer Drugs Testing Solutions for Employers

Designer Drugs

Page 39: Designer Drugs Testing Solutions for Employers

NMS Labs Philosophy

NMS Labs is the industry leader in its ability to identify and stay current in an evolving and challenging designer drug market offering testing established and new and emerging drugs of abuse.